Stocks
G1 Therapeutics (GTHX) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -212.1% | -453.6% | -263.0% | -47.3% | -25.3% | |||
| Changes by years, y/y, % | -241pp | +191pp | +216pp | -39.4% | |||||
G1 Therapeutics. EBITDA margin, %
G1 Therapeutics. EBITDA margin, changes, pp
G1 Therapeutics (GTHX) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA margin, % | ? | -189.3% | 30.3% | -133.1% | -59.2% | -61.7% | -25.3% | |
| Changes by years, y/y, % | +489pp | +379pp | -43pp | +234pp | +128pp | |||
| Changes by quarters, q/q, % | +104pp | +220pp | -163pp | +74pp | -2pp | |||
